APA

De Moerloose B., Suciu S., Bertrand Y., Mazingue F., Robert A., Uyttebroeck A., Yakouben K., Ferster A., Margueritte G., Lutz P., Munzer M., Sirvent N., Norton L., Boutard P., Plantaz D., Millot F., Philippet P., Baila L., Benoit Y. & Otten J. (20100824). Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951. : Blood.

Chicago

De Moerloose Barbara, Suciu Stefan, Bertrand Yves, Mazingue Françoise, Robert Alain, Uyttebroeck Anne, Yakouben Karima, Ferster Alice, Margueritte Geneviève, Lutz Patrick, Munzer Martine, Sirvent Nicolas, Norton Lucilia, Boutard Patrick, Plantaz Dominique, Millot Frederic, Philippet Pierre, Baila Liliana, Benoit Yves and Otten Jacques. 20100824. Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951. : Blood.

Harvard

De Moerloose B., Suciu S., Bertrand Y., Mazingue F., Robert A., Uyttebroeck A., Yakouben K., Ferster A., Margueritte G., Lutz P., Munzer M., Sirvent N., Norton L., Boutard P., Plantaz D., Millot F., Philippet P., Baila L., Benoit Y. and Otten J. (20100824). Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951. : Blood.

MLA

De Moerloose Barbara, Suciu Stefan, Bertrand Yves, Mazingue Françoise, Robert Alain, Uyttebroeck Anne, Yakouben Karima, Ferster Alice, Margueritte Geneviève, Lutz Patrick, Munzer Martine, Sirvent Nicolas, Norton Lucilia, Boutard Patrick, Plantaz Dominique, Millot Frederic, Philippet Pierre, Baila Liliana, Benoit Yves and Otten Jacques. Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951. : Blood. 20100824.